RobertIFoxMD

Internal Medicine • San Diego, CA

Allergy & Immunology

Prof of Medicine (Emeritus), Scripps Clinic and Research Foundation

Join to view full profile

Dr. Fox is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Fox's full profile

Already have an account?

Office
4206 Caminito Cassis
San Diego, CA 92122
Phone+1 858-945-1064

Fax+1 619-615-2317

Education & Training

Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1979 - 1979
Stanford Health Care-Sponsored Stanford UniversityFellowship, Allergy and Immunology, 1978 - 1978
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1977 - 1978
Stanford Health Care-Sponsored Stanford UniversityResidency, Pediatrics, 1976 - 1977
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1974 - 1976
Harvard Medical SchoolClass of 1974

Certifications & Licensure

CA State Medical License 1976 - 2026
American Board of Internal Medicine Internal Medicine
American College of RheumatologyFellow

Awards, Honors, & Recognition

Distinguished Fellow World Health Organization, 1985-2021
Broadhurst Distinguished Alumni Award Harvard University, 1998
Honorary Member Indian Academy of Medicine, 1995
Honorary Member National Academy of Medicine of Peoples Republic of China, 1986
Join now to see all

Clinical Trials

Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel Start of enrollment: 2018 Sep 03
Recruiting
Phase 3
Etanercept (Enbrel) in Undifferentiated Spondyloarthritis Start of enrollment: 2002 Feb 01
Unknown status
Phase 2
Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome Start of enrollment: 2022 Aug 04
Recruiting
Phase 3
Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome Start of enrollment: 2022 Jul 28
Active, not recruiting
Phase 3
DNA Exome Sequencing TCM for Sjögren's Syndrome Start of enrollment: 2019 Apr 01
Active, not recruiting
Olfactory and Taste Disturbances in Sjogren's Syndrome Start of enrollment: 2022 Jul 01
Not yet recruiting
Not Applicable
A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS) Start of enrollment: 2021 Sep 21
Completed
Phase 2
Assessment of 14-3-3 η (Eta) Protein Antibodies in the Serum of Rheumatoid Arthritis Patients and Its Relation to Atherosclerosis. Start of enrollment: 2021 Sep 01
Not yet recruiting
Association Between Methotrexate Erythrocyte Polyglutamate Concentration and Clinical Response in Rheumatoid Arthritis Patients Treated With Subcutaneous Injectable Methotrexate Start of enrollment: 2018 Jul 02
Completed
Phase 4
Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS) Start of enrollment: 2017 Jun 27
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Axial Articular Manifestations in Primary Sjögren Syndrome: Have We Been Missing Spondyloarthritis for All This Time?
Robert I. Fox, Carla M. Fox
The Journal of Rheumatology. 2021-04-01
67 citations
Sjögren's syndrome: mechanisms of pathogenesis involve interaction of immune and neurosecretory systems.
Robert I. Fox, Michael E. Stern
Scandinavian Journal of Rheumatology. Supplement. 2002-01-01

Journal Articles

Sjogren Syndrome
Robert Fox, Arthritis and Rheumatism
Role of high endothelial venues in Sjögren's syndrome
Robert Fox, Sciene
Pathogenesis and Treatment of Sjögren's syndrome
Robert Fox, New England Journal of Medicine

Books/Book Chapters

Sjögren's syndrome
Robert Foxelsevier

Committees

Member, Sjogren Syndrome 1991 - 2022

Professional Memberships

American College of Rheumatology - ACR
Member